-
1
-
-
0035810147
-
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
-
(2001)
N Engl J Med
, vol.344
, pp. 1031-1037
-
-
Druker, B.J.1
Talpaz, M.2
Resta, D.J.3
Peng, B.4
Buchdunger, E.5
Ford, J.M.6
Lydon, N.B.7
Kantarjian, H.8
Capdeville, R.9
Ohno-Jones, S.10
Sawyers, C.L.11
-
2
-
-
0035810142
-
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
-
(2001)
N Engl J Med
, vol.344
, pp. 1038-1042
-
-
Druker, B.J.1
Sawyers, C.L.2
Kantarjian, H.3
Resta, D.J.4
Reese, S.F.5
Ford, J.M.6
Capdeville, R.7
Talpaz, M.8
-
3
-
-
0029153841
-
Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha
-
(1995)
Leuk Lymphoma
, vol.18
, pp. 471-478
-
-
Pawelec, G.1
Da Silva, P.2
Max, H.3
Kalbacher, H.4
Schmidt, H.5
Bruserud, O.6
Zugel, U.7
Baier, W.8
Rehbein, A.9
Pohla, H.10
-
8
-
-
0034955141
-
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis
-
(2001)
Ann Neurol
, vol.50
, pp. 121-127
-
-
McDonald, W.I.1
Compston, A.2
Edan, G.3
Goodkin, D.4
Hartung, H.P.5
Lublin, F.D.6
McFarland, H.F.7
Paty, D.W.8
Polman, C.H.9
Reingold, S.C.10
Sandberg-Wollheim, M.11
Sibley, W.12
Thompson, A.13
Van den Noort, S.14
Weinshenker, B.Y.15
Wolinsky, J.S.16
-
9
-
-
0021035886
-
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
-
(1983)
Neurology
, vol.33
, pp. 1444-1452
-
-
Kurtzke, J.F.1
-
13
-
-
0020523189
-
Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells
-
(1983)
J Immunol
, vol.131
, pp. 1300-1305
-
-
Broxmeyer, H.E.1
Lu, L.2
Platzer, E.3
Feit, C.4
Juliano, L.5
Rubin, B.Y.6
-
14
-
-
0025367456
-
Recombinant interferon-alpha-2C in chronic myelogenous leukemia: Relationship of sensitivity of committed hematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response
-
(1990)
Leuk Res
, vol.14
, pp. 629-636
-
-
Geissler, D.1
Gastl, G.2
Aulitzky, W.3
Tilg, H.4
Gaggl, S.5
Konwalinka, G.6
Huber, C.7
-
15
-
-
0026332785
-
Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells
-
(1991)
J Clin Invest
, vol.88
, pp. 2131-2136
-
-
Upadhyaya, G.1
Guba, S.C.2
Sih, S.A.3
Feinberg, A.P.4
Talpaz, M.5
Kantarjian, H.M.6
Deisseroth, A.B.7
Emerson, S.G.8
-
17
-
-
0029111697
-
Treatment of marrow stroma with interferon-alpha restores normal beta I integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-alpha
-
(1995)
J Clin Invest
, vol.96
, pp. 931-939
-
-
Bhatia, R.1
McGlave, P.B.2
Verfaillie, C.M.3
-
18
-
-
0030969311
-
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia
-
(1997)
Blood
, vol.89
, pp. 957-964
-
-
Selleri, C.1
Sato, T.2
Del Vecchio, L.3
Luciano, L.4
Barrett, A.J.5
Rotoli, B.6
Young, N.S.7
Maciejewski, J.P.8
-
21
-
-
0032526030
-
Biological properties of recombinant α-interferons: 40th Anniversary of the discovery of interferons
-
(1998)
Cancer Res
, vol.58
, pp. 2489-2499
-
-
Pfeffer, L.M.1
Dinarello, C.A.2
Herberman, R.B.3
Williams, B.R.4
Borden, E.C.5
Bordens, R.6
Walter, M.R.7
Nagabhushan, T.L.8
Trotta, P.P.9
Pestka, S.10
-
22
-
-
0035134688
-
Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities
-
(2001)
Oncologist
, vol.6
, pp. 34-55
-
-
Jonasch, E.1
Haluska, F.G.2
-
23
-
-
0028348216
-
Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis
-
(1994)
Neurology
, vol.44
, pp. 406-413
-
-
Durelli, L.1
Bongioanni, M.R.2
Cavallo, R.3
Ferrero, B.4
Ferri, R.5
Ferrio, M.F.6
Bradac, G.B.7
Riva, A.8
Vai, S.9
Geuna, M.10
Bergamini, L.11
Bergamasco, B.12
-
26
-
-
0027156946
-
Effects of recombinant α2b-interferon therapy in patients with progressive MS
-
(1993)
Acta Neurol Scand
, vol.87
, pp. 457-460
-
-
Kinnunen, E.1
Timonen, T.2
Pirttila, T.3
Kalliomaki, P.4
Ketonen, L.5
Matikainen, E.6
Sepponen, R.7
Juntunen, J.8
|